Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACRV Acrivon Therapeutics, Inc.

休市中 03-20 16:00:00 EDT

1.66

-0.04

-2.35%

盘后1.68

+0.02+1.09%

18:48 EDT

最高1.74	最低1.65	成交量45.13万
今开1.69	昨收1.70	日振幅5.59%
总市值6,432万	流通市值3,989万	总股本3,874万
成交额75.97万	换手率1.88%	流通股本2,403万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACRV","market":"US","secType":"STK","nameCN":"Acrivon Therapeutics, Inc.","latestPrice":1.66,"timestamp":1774036800000,"preClose":1.7,"halted":0,"volume":451303,"hourTrading":{"tag":"盘后","latestPrice":1.6781,"preClose":1.66,"latestTime":"18:48 EDT","volume":24236,"amount":40247.5225,"timestamp":1774046907047,"change":0.0181,"changeRate":0.010904,"amplitude":0.016928},"delay":0,"changeRate":-0.023529411764705903,"floatShares":24032900,"shares":38744446,"eps":-2.128243,"marketStatus":"休市中","change":-0.04,"latestTime":"03-20 16:00:00 EDT","open":1.69,"high":1.74,"low":1.645,"amount":759694.225766,"amplitude":0.055882,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.128243,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"listingDate":1668488400000,"exchange":"NASDAQ","adjPreClose":1.7,"preHourTrading":{"tag":"盘前","latestPrice":1.65,"preClose":1.7,"latestTime":"09:22 EDT","volume":12043,"amount":19948.639393,"timestamp":1774012945749,"change":-0.05,"changeRate":-0.029412,"amplitude":0.028647},"postHourTrading":{"tag":"盘后","latestPrice":1.6781,"preClose":1.66,"latestTime":"18:48 EDT","volume":24236,"amount":40247.5225,"timestamp":1774046907047,"change":0.0181,"changeRate":0.010904,"amplitude":0.016928},"volumeRatio":0.5782786846533805},"requestUrl":"/m/hq/s/ACRV","defaultTab":"news","newsList":[{"id":"1167961172","title":"Acrivon Therapeutics公布2025年第四季度及全年财务业绩与近期业务亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=1167961172","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167961172?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:23","pubTimestamp":1773919394,"startTime":"0","endTime":"0","summary":"Acrivon Therapeutics, Inc.（简称“Acrivon Therapeutics”）正式发布了其2025财年第四季度及全年的财务报告，同时概述了公司在过去一段时间内的关键业务进展。此次披露的信息涵盖了公司在财务表现和战略发展方面的最新动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRV","BK4139"],"gpt_icon":0},{"id":"1164017266","title":"Acrivon Therapeutics 通过启动内部CLIA认证实验室强化精准医疗治疗能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1164017266","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164017266?lang=zh_cn&edition=full","pubTime":"2026-02-18 21:03","pubTimestamp":1771419790,"startTime":"0","endTime":"0","summary":"Acrivon Therapeutics, Inc. 近日宣布启动其内部CLIA认证实验室，此举显著增强了该公司在精准医疗治疗领域的专业能力。这一战略举措将进一步提升其药物研发的精确度与效率，为患者提供更个性化的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRV","BK4139"],"gpt_icon":0},{"id":"1172000722","title":"Acrivon Therapeutics公布Acr-368子宫内膜癌二期B组临床试验积极数据，欧盟扩展加速患者招募，首次披露Acr-2316临床数据及靶向Cdk11的新候选药物Acr-6840","url":"https://stock-news.laohu8.com/highlight/detail?id=1172000722","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172000722?lang=zh_cn&edition=full","pubTime":"2026-01-08 20:32","pubTimestamp":1767875529,"startTime":"0","endTime":"0","summary":"Acrivon Therapeutics宣布其靶向药物Acr-368在二期B组子宫内膜癌临床试验中取得积极结果。为加速患者招募进程，公司同步启动欧盟地区临床扩展计划。本次公告同时首次披露了双特异性候选药物Acr-2316的初步临床数据，并正式推出基于AP3精准蛋白组学平台开发的下一代候选药物Acr-6840，该药物主要靶向细胞周期关键调控因子Cdk11蛋白。最新数据显示，Acr-368在经生物标志物筛选的子宫内膜癌患者群体中展现出显著临床活性，具体疗效指标将于后续医学会议公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACRV"],"gpt_icon":0},{"id":"1193087336","title":"Acrivon Therapeutics将公布其Acr-368正在进行的2B阶段研究及计划的确认性3期试验的临床进展，同时更新Acr-2316的初步临床数据及其他AP3管线进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1193087336","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193087336?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:35","pubTimestamp":1765974918,"startTime":"0","endTime":"0","summary":"Acrivon Therapeutics将公布其Acr-368正在进行的2B阶段研究及计划的确认性3期试验的临床进展，同时更新Acr-2316的初步临床数据及其他AP3管线进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRV","BK4139"],"gpt_icon":0},{"id":"1161495692","title":"Acrivon Therapeutics, Inc 第三季度运营收入为 -1968.7 万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161495692","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161495692?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:27","pubTimestamp":1763069220,"startTime":"0","endTime":"0","summary":"11月13日 - Acrivon Therapeutics, Inc 第三季度运营费用为1968.7万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRV","BK4139"],"gpt_icon":0},{"id":"2517929782","title":"Acrivon Therapeutics, Inc.盘中异动 股价大涨7.28%报5.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517929782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517929782?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:46","pubTimestamp":1741207591,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时46分，Acrivon Therapeutics, Inc.股票出现波动，股价急速拉升7.28%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.96%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306044631963b2d7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306044631963b2d7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACRV","BK4139"],"gpt_icon":0},{"id":"2514383701","title":"Acrivon Therapeutics, Inc.盘中异动 早盘股价大涨7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514383701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514383701?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:38","pubTimestamp":1740667111,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时38分，Acrivon Therapeutics, Inc.股票出现异动，股价大幅上涨7.06%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223831abdf7090&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223831abdf7090&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","BK4139","LENZ"],"gpt_icon":0},{"id":"2513224827","title":"Acrivon Therapeutics, Inc.盘中异动 快速上涨7.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513224827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513224827?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407509,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，Acrivon Therapeutics, Inc.股票出现异动，股价急速拉升7.58%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242231499890f59a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242231499890f59a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2512719612","title":"Acrivon Therapeutics, Inc.盘中异动 股价大跌5.24%报5.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512719612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512719612?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:09","pubTimestamp":1739905781,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时09分，Acrivon Therapeutics, Inc.股票出现波动，股价大幅下跌5.24%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219030941abd3e851&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219030941abd3e851&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","BK4139","LENZ"],"gpt_icon":0},{"id":"2509028280","title":"Acrivon Therapeutics, Inc.盘中异动 快速拉升7.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509028280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509028280?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:38","pubTimestamp":1738766310,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时38分，Acrivon Therapeutics, Inc.股票出现异动，股价急速上涨7.28%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020522383196190a32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020522383196190a32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACRV","LENZ"],"gpt_icon":0},{"id":"2509927114","title":"Acrivon Therapeutics, Inc.盘中异动 临近收盘股价大涨6.10%报5.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509927114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509927114?lang=zh_cn&edition=full","pubTime":"2025-02-05 05:01","pubTimestamp":1738702908,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日05时01分，Acrivon Therapeutics, Inc.股票出现波动，股价急速上涨6.10%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020505014896181387&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020505014896181387&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2508149809","title":"Acrivon Therapeutics, Inc.盘中异动 急速下挫10.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508149809?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593331,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Acrivon Therapeutics, Inc.股票出现异动，股价急速跳水10.05%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223532abc10805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223532abc10805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","BK4139","LENZ"],"gpt_icon":0},{"id":"2507672448","title":"Acrivon Therapeutics, Inc.盘中异动 股价大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507672448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507672448?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:37","pubTimestamp":1738265835,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时37分，Acrivon Therapeutics, Inc.股票出现波动，股价大幅拉升5.65%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131033715abbd8012&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131033715abbd8012&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2503454647","title":"Acrivon Therapeutics, Inc.盘中异动 早盘快速上涨5.02%报5.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503454647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503454647?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951544,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Acrivon Therapeutics, Inc.股票出现波动，股价大幅上涨5.02%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223224ababf27f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223224ababf27f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ACRV"],"gpt_icon":0},{"id":"2500092736","title":"Acrivon Therapeutics, Inc.盘中异动 早盘股价大涨6.28%报6.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500092736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500092736?lang=zh_cn&edition=full","pubTime":"2025-01-02 22:37","pubTimestamp":1735828620,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日22时37分，Acrivon Therapeutics, Inc.股票出现异动，股价急速拉升6.28%。截至发稿，该股报6.40美元/股，成交量3839股，换手率0.01%，振幅3.12%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010222370095f696fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010222370095f696fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACRV","LENZ"],"gpt_icon":0},{"id":"2494868335","title":"Acrivon Therapeutics, Inc.盘中异动 大幅下跌5.49%报5.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494868335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494868335?lang=zh_cn&edition=full","pubTime":"2024-12-28 01:29","pubTimestamp":1735320593,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日01时29分，Acrivon Therapeutics, Inc.股票出现异动，股价急速下跌5.49%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122801295395ef9929&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122801295395ef9929&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","BK4139","LENZ"],"gpt_icon":0},{"id":"2486946004","title":"Acrivon Therapeutics, Inc.盘中异动 早盘大幅拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486946004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486946004?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:54","pubTimestamp":1732632850,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时54分，Acrivon Therapeutics, Inc.股票出现异动，股价急速拉升5.11%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126225410a257506d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126225410a257506d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ACRV"],"gpt_icon":0},{"id":"2486303542","title":"Acrivon Therapeutics, Inc.盘中异动 股价大涨5.65%报6.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486303542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486303542?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:49","pubTimestamp":1732546144,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时49分，Acrivon Therapeutics, Inc.股票出现波动，股价大幅上涨5.65%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224904a2549600&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224904a2549600&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACRV","LENZ"],"gpt_icon":0},{"id":"2484053326","title":"Acrivon Therapeutics, Inc.盘中异动 临近午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484053326","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484053326?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:50","pubTimestamp":1731948618,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日00时50分，Acrivon Therapeutics, Inc.股票出现波动，股价急速下跌5.03%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900501898e434fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900501898e434fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2483530486","title":"Acrivon Therapeutics, Inc.2024财年第三财季实现净利润-22.44百万美元，同比减少55.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483530486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483530486?lang=zh_cn&edition=full","pubTime":"2024-11-16 08:02","pubTimestamp":1731715360,"startTime":"0","endTime":"0","summary":"11月16日，Acrivon Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-22.44百万美元，同比减少55.08%；其中营业收入为0.00美元，每股基本收益为-0.59美元。机构评级：截至2024年11月16日，当前有9家机构对Acrivon Therapeutics, Inc.目标价做出预测，其中目标均价为21.56美元，其中最低目标价为16.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116080241abc5e514&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116080241abc5e514&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acrivon.com","stockEarnings":[{"period":"1week","weight":0.0247},{"period":"1month","weight":0.044},{"period":"3month","weight":-0.2315},{"period":"6month","weight":0.0184},{"period":"1year","weight":-0.677},{"period":"ytd","weight":-0.3112}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acrivon Therapeutics, Inc.于2018年3月在特拉华州注册成立。该公司是一家临床阶段生物制药公司，开发精确的肿瘤药物，该公司利用其专有的基于蛋白质组学的患者应答者识别平台，将其与肿瘤预测对每种特定药物敏感的患者相匹配。该公司通过使用其专有的精密药物平台AP3来开发其候选肿瘤药物管道。（该公司的AP3平台能够创建药物专用专有OncoSignature伴随诊断，用于识别最有可能从该公司候选药物中获益的患者，该公司称之为患者应答者）。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.025209},{"month":2,"riseRate":0.5,"avgChangeRate":0.076049},{"month":3,"riseRate":0.5,"avgChangeRate":-0.105666},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.022987},{"month":5,"riseRate":0,"avgChangeRate":-0.147923},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.005067},{"month":7,"riseRate":0.666667,"avgChangeRate":0.160112},{"month":8,"riseRate":0.666667,"avgChangeRate":0.040485},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.031978},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.069859},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.031223},{"month":12,"riseRate":0.5,"avgChangeRate":-0.018326}],"exchange":"NASDAQ","name":"Acrivon Therapeutics, Inc.","nameEN":"Acrivon Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acrivon Therapeutics, Inc.(ACRV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acrivon Therapeutics, Inc.,ACRV,Acrivon Therapeutics, Inc.股票,Acrivon Therapeutics, Inc.股票老虎,Acrivon Therapeutics, Inc.股票老虎国际,Acrivon Therapeutics, Inc.行情,Acrivon Therapeutics, Inc.股票行情,Acrivon Therapeutics, Inc.股价,Acrivon Therapeutics, Inc.股市,Acrivon Therapeutics, Inc.股票价格,Acrivon Therapeutics, Inc.股票交易,Acrivon Therapeutics, Inc.股票购买,Acrivon Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acrivon Therapeutics, Inc.(ACRV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}